Source: Therapeutic Advances in Musculoskeletal Disease. Unidades: FMRP, FCFRP
Subjects: BIOMARCADORES, CÉLULAS, ENDOTÉLIO, DOENÇA CRÔNICA
ABNT
GONÇALVES, Maynara Santana et al. Autologous hematopoietic stem cell transplantation modifies specific aspects of systemic sclerosis-related microvasculopathy. Therapeutic Advances in Musculoskeletal Disease, v. 14, p. 1- 13, 2022Tradução . . Disponível em: https://doi.org/10.1177/1759720X221084845. Acesso em: 06 nov. 2024.APA
Gonçalves, M. S., Silva, D. C. Z. da, Henrique Neto, Á., Moraes, D. A. de, Vasconcelos, M. Y. K., Lima Júnior, J. R., et al. (2022). Autologous hematopoietic stem cell transplantation modifies specific aspects of systemic sclerosis-related microvasculopathy. Therapeutic Advances in Musculoskeletal Disease, 14, 1- 13. doi:10.1177/1759720X221084845NLM
Gonçalves MS, Silva DCZ da, Henrique Neto Á, Moraes DA de, Vasconcelos MYK, Lima Júnior JR, Dias JBE, Bragagnollo V, Azevedo JTC de, Covas DT, Farias KCRM de, Ramalho LNZ, Rodrigues MC de O. Autologous hematopoietic stem cell transplantation modifies specific aspects of systemic sclerosis-related microvasculopathy [Internet]. Therapeutic Advances in Musculoskeletal Disease. 2022 ; 14 1- 13.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1177/1759720X221084845Vancouver
Gonçalves MS, Silva DCZ da, Henrique Neto Á, Moraes DA de, Vasconcelos MYK, Lima Júnior JR, Dias JBE, Bragagnollo V, Azevedo JTC de, Covas DT, Farias KCRM de, Ramalho LNZ, Rodrigues MC de O. Autologous hematopoietic stem cell transplantation modifies specific aspects of systemic sclerosis-related microvasculopathy [Internet]. Therapeutic Advances in Musculoskeletal Disease. 2022 ; 14 1- 13.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1177/1759720X221084845